2012·Master of Medicine in Obstetrics and Gynaecology Jessica Mulindwa·University of Zambia
Background: The toxicity of nevirapine based regimen in pregnant women with CD4 counts greater than 250 cells/mm3 is well documented. WHO as well as the United States Food and Drug Agency (US FDA) cautions use of nevirapine in pregnant women with CD4 counts greater than 250 cells/mm3. The Zambian...
Download PDF ↓